# The Lancet Oncology

Source: https://nuclide.cc/journals/lancet-oncology/  
Nuclide record `lancet-oncology` (Journal). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

The Lancet Oncology is the leading specialist cancer journal for clinical trials. It publishes phase 2 and 3 trials, long-term follow-up, quality-of-life analyses and global-oncology policy Commissions.

## Summary

The Lancet Oncology appears monthly plus online-first and publishes a large share of randomised oncology trials that do not go to NEJM, with particular strength in radiotherapy, surgery, supportive care and health-system studies (IBIS-I tamoxifen prevention, MASAI AI mammography, GAP70 geriatric assessment in this corpus). Its Commissions and Series drive policy debates on drug pricing, radiotherapy access and cancer in low-income countries. Elsevier hybrid model; abstracts free.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: Lancet Oncol; src-lancet-oncology
- Publisher: Elsevier
- Scope: clinical oncology
- Access: hybrid

## Notes

- Holds: Phase 2 and 3 trials, meta-analyses, global oncology policy and the ESMO-aligned commentaries. Access: Paywalled; abstracts free.

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/The_Lancet_Oncology
- Lancet Oncology Commissions: https://www.thelancet.com/journals/lanonc/commissions

## Connected records

- people: [Pierre Vera](https://nuclide.cc/people/pierre-vera/)

---
JSON: https://nuclide.cc/api/v1/entities/lancet-oncology.json